(Q45164954)

10 December 2017

0 references

Anticoagulants, renal failure and atrial fibrillation (English)

1 reference

10 December 2017

1 reference

1 reference

1 reference

Simonetta Genovesi

1

1 reference

PubMed ID

23163428

10 December 2017

Antonio Santoro

series ordinal

2

1 reference

PubMed ID

23163428

10 December 2017

language of work or name

English

0 references

publication date

20 November 2012

1 reference

Expert Opinion on Drug Safety

10 December 2017

1 reference

10 December 2017

12

1 reference

10 December 2017

1

1 reference

10 December 2017

1-3

1 reference

The increasing prevalence of atrial fibrillation among hemodialysis patients

10 December 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Ischaemic stroke in incident dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Elevated risk of stroke among patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Platelet dysfunction in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.746661

10.1517/14740338.2013.746661

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

23163428